CSPC PHARMACEUTICAL GROUP LTD. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 6.44 HKD | -4.31% |
|
-4.87% | -11.29% |
| Jun. 12 | CSPC Pharmaceutical Buys Back Further Shares | MT |
| Jun. 11 | CSPC Pharmaceutical Repurchases 7 Million Shares | MT |
ETFs positioned on CSPC Pharmaceutical Group Ltd.
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.01% | 8 M€ | +0.67% | - | |
| 0.01% | 55 M€ | +2.13% | - | |
| 0.00% | 15 M€ | +18.63% |
CSPC Pharmaceutical Group Ltd. specializes in the development, manufacture and marketing of pharmaceutical products. Net sames by category of products break down as follows:
- drugs (78.7%): innovative drugs (62.5% of sales) and common generic drugs (37.5%);
- vitamin C (10.1%);
- antibiotics (6.2%);
- other (5%): including anhydrous and raw caffeine.
Net sales are distributed geographically as follows: China (82.8%), Asia (7.2%), Europe (4.6%), the Americas (4.4%) and others (1%).
Sector
Pharmaceuticals
Calendar
2024-08-20
- Q2 2024 Earnings Release (Projected)
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
B
Sell
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
6.44
HKD
Average target price
9.584
HKD
Spread / Average Target
+48.82%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -11.29% | 10.21B | |
| +51.99% | 803B | |
| -5.72% | 351B | |
| +18.94% | 324B | |
| +11.07% | 303B | |
| +16.96% | 243B | |
| +2.25% | 228B | |
| +11.15% | 217B | |
| +7.59% | 164B | |
| -3.65% | 155B |
- Stock Market
- Equities
- 1093 Stock
- Funds and ETFs CSPC Pharmaceutical Group Ltd.
